Telix Pharmaceuticals Ltd. (TLX)
9.56
+0.30
(+3.24%)
USD |
NASDAQ |
Oct 29, 12:21
Telix Pharmaceuticals Market Cap : 3.248B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 3.146B |
| October 27, 2026 | 3.068B |
| October 26, 2026 | 3.055B |
| October 23, 2026 | 3.109B |
| October 22, 2026 | 3.242B |
| October 21, 2026 | 3.408B |
| October 20, 2026 | 3.792B |
| October 19, 2026 | 3.649B |
| October 16, 2026 | 3.632B |
| October 15, 2026 | 3.592B |
| October 14, 2026 | 3.619B |
| October 13, 2026 | 3.710B |
| October 12, 2026 | 3.836B |
| October 09, 2026 | 3.809B |
| October 08, 2026 | 3.741B |
| October 07, 2026 | 3.778B |
| October 06, 2026 | 3.663B |
| October 05, 2026 | 3.697B |
| October 02, 2026 | 3.585B |
| October 01, 2026 | 3.642B |
| September 30, 2026 | 3.727B |
| September 29, 2026 | 3.853B |
| September 28, 2026 | 3.948B |
| September 25, 2026 | 3.891B |
| September 24, 2026 | 3.843B |
| Date | Value |
|---|---|
| September 23, 2026 | 3.829B |
| September 22, 2026 | 4.060B |
| September 21, 2026 | 3.843B |
| September 18, 2026 | 4.278B |
| September 17, 2026 | 4.249B |
| September 16, 2026 | 4.020B |
| September 15, 2026 | 4.359B |
| September 14, 2026 | 4.003B |
| September 11, 2026 | 3.836B |
| September 10, 2026 | 4.043B |
| September 09, 2026 | 4.193B |
| September 08, 2026 | 4.071B |
| September 04, 2026 | 4.057B |
| September 03, 2026 | 3.989B |
| September 02, 2026 | 3.891B |
| September 01, 2026 | 3.687B |
| August 31, 2026 | 3.768B |
| August 28, 2026 | 3.836B |
| August 27, 2026 | 3.865B |
| August 26, 2026 | 3.782B |
| August 25, 2026 | 3.972B |
| August 24, 2026 | 3.969B |
| August 21, 2026 | 3.850B |
| August 20, 2026 | 4.220B |
| August 19, 2026 | 4.118B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mesoblast Ltd. | 2.014B |
| Immutep Ltd. | 24.17M |
| CSL Ltd. | 66.59B |
| Ceryvyn Therapeutics Ltd. | 3.95M |
| Propanc Biopharma, Inc. | 7.218M |
Market Cap Related Metrics
| PE Ratio | 102.25 |
| PS Ratio | 3.723 |
| Price to Book Value | 27.03 |
| Price | 9.56 |
| Earnings Yield | 0.98% |
| Normalized PE Ratio | 175.09 |